GRAIL, Inc. (GRAL)
140.92
+3.55
(+2.58%)
USD |
NASDAQ |
Oct 13, 15:45
GRAIL Total Assets (Quarterly) : 2.844B for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.844B |
| March 31, 2026 | 2.803B |
| December 31, 2025 | 3.178B |
| September 30, 2025 | 2.601B |
| June 30, 2025 | 2.703B |
| March 31, 2025 | 2.848B |
| December 31, 2024 | 3.142B |
| September 30, 2024 | 3.118B |
| June 30, 2024 | 3.270B |
| March 31, 2024 | 3.973B |
| December 31, 2023 | 4.557B |
| September 30, 2023 |
| Date | Value |
|---|---|
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | 727.47M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Moderna, Inc. | 10.96B |
| Twist Bioscience Corp. | 672.44M |
| Prime Medicine, Inc. | 249.04M |
| Kailera Therapeutics, Inc. | 1.211B |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 301.03M |
| Shareholders Equity (Quarterly) | 2.543B |
| Debt to Equity Ratio | 0.0359 |
| Current Ratio | 10.95 |
| Net Debt Paydown Yield | -0.18% |